Editas Medicine to Host Conference Call Discussing Third Quarter 2016 Corporate Update and Results
October 31, 2016 16:01 ET
|
Editas Medicine
CAMBRIDGE, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on...
Editas Medicine to Present at the Jefferies Gene Editing/Therapy Summit
October 03, 2016 16:01 ET
|
Editas Medicine
CAMBRIDGE, Mass., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, announced today that it will present at 9:00 a.m. ET and participate in a...
Editas Medicine to Present at the Morgan Stanley Global Healthcare Conference
September 06, 2016 16:01 ET
|
Editas Medicine
CAMBRIDGE, Mass., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present at the Morgan Stanley Global...
Editas Medicine Announces Second Quarter 2016 Results and Update
August 09, 2016 16:01 ET
|
Editas Medicine
Exclusive license to high-fidelity Cas9 and Cas9 PAM variants from Massachusetts General Hospital further advances leading genome editing platform Strategic partnership with Adverum to explore...
Editas Medicine to Host Conference Call Discussing Second Quarter 2016 Corporate Update and Results
August 02, 2016 16:01 ET
|
Editas Medicine
CAMBRIDGE, Mass., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on...
Editas Medicine to Present at Upcoming June Investor Conferences
May 24, 2016 16:01 ET
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., May 24, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present company overviews at three upcoming...
Editas Medicine Announces First Quarter 2016 Results and Update
May 16, 2016 07:30 ET
|
Editas Medicine, Inc.
Advancing pipeline and platform demonstrated by data presented at medical and scientific conferences as well as achievement of Juno Therapeutics milestone Strengthened effort to develop medicines...
Editas Medicine to Host Conference Call Discussing First Quarter 2016 Corporate Update and Results
May 09, 2016 08:00 ET
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., May 09, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Monday,...
Editas Medicine Achieves Milestone under its Collaboration with Juno Therapeutics
May 04, 2016 07:30 ET
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, announced today that it has achieved a $2.5 million milestone under its...
Editas Medicine to Present at Deutsche Bank 41st Annual Health Care Conference
April 27, 2016 08:00 ET
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., April 27, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present a company overview at the Deutsche...